Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine.
- DOI
- 10.1016/j.xcrm.2022.100716
- Published
- 2022-08-04
- Container
- Cell Rep Med
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.xcrm.2022.100716,
title = {Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine.},
author = {Naaber P and Tserel L and Kangro K and Punapart M and Sepp E and Jürjenson V and Kärner J and Haljasmägi L and Haljasorg U and Kuusk M and Sankovski E and Planken A and Ustav M and Žusinaite E and Gerhold JM and Kisand K and Peterson P.},
year = {2022},
journal = {Cell Rep Med},
doi = {10.1016/j.xcrm.2022.100716},
url = {https://doi.org/10.1016/j.xcrm.2022.100716}
}RIS
TY - JOUR TI - Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine. AU - Naaber P AU - Tserel L AU - Kangro K AU - Punapart M AU - Sepp E AU - Jürjenson V AU - Kärner J AU - Haljasmägi L AU - Haljasorg U AU - Kuusk M AU - Sankovski E AU - Planken A AU - Ustav M AU - Žusinaite E AU - Gerhold JM AU - Kisand K AU - Peterson P. PY - 2022 JO - Cell Rep Med DO - 10.1016/j.xcrm.2022.100716 UR - https://doi.org/10.1016/j.xcrm.2022.100716 ER -
APA
P, N., L, T., K, K., M, P., E, S., V, J., J, K., L, H., U, H., M, K., E, S., A, P., M, U., E, Ž., JM, G., K, K., & P., P. (2022). Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine.. Cell Rep Med. https://doi.org/10.1016/j.xcrm.2022.100716
Source records
- europe-pmc · retrieved 2026-09-27T15:56:19.501Z